Drug-Coformer Loaded-Mesoporous Silica Nanoparticles: A Review of the Preparation, Characterization, and Mechanism of Drug Release

References

• Budiman A, Nurfadilah N, Muchtaridi M, Sriwidodo S, Aulifa DL, Rusdin A. The impact of water-soluble chitosan on the inhibition of crystal nucleation of alpha-mangostin from. Polymers. 2022;14(20):4370. doi:10.3390/polym14204370
   PubMed Web of Science ®Google Scholar
• Budiman A, Citraloka ZG, Muchtaridi M, Sriwidodo S, Aulifa DL, Rusdin A. Inhibition of crystal nucleation and growth in aqueous drug solutions: impact of different polymers on the supersaturation profiles of amorphous drugs—the case of alpha-mangostin. Pharmaceutics. 2022;14(11):2386. doi:10.3390/pharmaceutics14112386
   PubMed Web of Science ®Google Scholar
• Budiman A, Aulifa DL. Characterization of drugs with good glass formers in loaded-mesoporous silica and its theoretical value relevance with mesopores surface and pore-filling capacity. Pharmaceuticals. 2022;15(1):1–16. doi:10.3390/ph15010093
   Web of Science ®Google Scholar
• Al-Kassas R, Bansal M, Shaw J. Nanosizing techniques for improving bioavailability of drugs. J Control Release. 2017;260(28):202–212. doi:10.1016/j.jconrel.2017.06.003
   PubMedGoogle Scholar
• Johnson JLH, He Y, Yalkowsky SH. Prediction of precipitation-induced phlebitis: a statistical validation of an in vitro model. J Pharm Sci. 2003;92(8):1574–1581. doi:10.1002/jps.10396
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci. 1996;85(10):1017–1025. doi:10.1021/js950534b
   PubMed Web of Science ®Google Scholar
• Skorupska E, Paluch P, Jeziorna A, Potrzebowski MJ. NMR study of BA/FBA cocrystal confined within mesoporous silica nanoparticles employing thermal solid phase transformation. J Phys Chem C. 2015;119(16):8652–8661. doi:10.1021/jp5123008
   Web of Science ®Google Scholar
• Yu L. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv Drug Deliv Rev. 2001;48(1):27–42. doi:10.1016/S0169-409X(01)00098-9
   PubMed Web of Science ®Google Scholar
• Hancock BC, Parks M. What is the true solubility advantage of amorphous pharmaceuticals? Pharm Res. 2000;17:397–403. doi:10.1023/A:1007516718048
   PubMed Web of Science ®Google Scholar
• Azad M, Moreno J, Davé R. Stable and fast-dissolving amorphous drug composites preparation via impregnation of Neusilin® UFL2. J Pharm Sci. 2018;107(1):170–182. doi:10.1016/j.xphs.2017.10.007
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Kojima T, Karashima M, Ikeda Y. Physicochemical evaluation and developability assessment of co-amorphouses of low soluble drugs and comparison to the co-crystals. Chem Pharm Bull. 2016;64(12):1739–1746. doi:10.1248/cpb.c16-00604
   PubMed Web of Science ®Google Scholar
• Moinuddin SM, Ruan S, Huang Y, et al. Facile formation of co-amorphous atenolol and hydrochlorothiazide mixtures via cryogenic-milling: enhanced physical stability, dissolution and pharmacokinetic profile. Int J Pharm. 2017;532(1):393–400. doi:10.1016/j.ijpharm.2017.09.020
   PubMedGoogle Scholar
• Newman A, Reutzel-Edens SM, Zografi G, et al. Coamorphous active pharmaceutical ingredient-small molecule mixtures: considerations in the choice of coformers for enhancing dissolution and oral bioavailability. J Pharm Sci. 2018;107:5–17. doi:10.1016/j.xphs.2017.09.024
   PubMed Web of Science ®Google Scholar
• Löbmann K, Grohganz H, Laitinen R, Strachan C, Rades T. Amino acids as co-amorphous stabilizers for poorly water soluble drugs - Part 1: preparation, stability and dissolution enhancement. Eur J Pharm Biopharm. 2013;85(3 PART B):873–881. doi:10.1016/j.ejpb.2013.03.014
   PubMed Web of Science ®Google Scholar
• Korhonen O, Pajula K, Laitinen R. Rational excipient selection for co-amorphous formulations. Expert Opin Drug Deliv. 2017;14(4):551–569. doi:10.1080/17425247.2016.1198770
   PubMed Web of Science ®Google Scholar
• Shi Q, Moinuddin SM, Cai T. Advances in coamorphous drug delivery systems. Acta Pharm Sin B. 2019;9(1):19–35. doi:10.1016/j.apsb.2018.08.002
   PubMed Web of Science ®Google Scholar
• Aitipamula S, Banerjee R, Bansal AK, et al. Polymorphs, salts, and cocrystals: what’s in a name? Cryst Growth Des. 2012;5(12):2147–2152. doi:10.1021/cg3002948
   Google Scholar
• Duggirala NK, Perry ML, Almarsson Ö, Zaworotko MJ. Pharmaceutical cocrystals: along the path to improved medicines. Chem Commun. 2016;52(4):640–655. doi:10.1039/c5cc08216a
   PubMed Web of Science ®Google Scholar
• Bavishi DD, Borkhataria CH. Spring and parachute: how cocrystals enhance solubility. Prog Cryst Growth Charact Mater. 2016;62(3):1–8. doi:10.1016/j.pcrysgrow.2016.07.001
   Web of Science ®Google Scholar
• Pallavi P, Harini K, Alshehri S, et al. From synthetic route of silica nanoparticles to theranostic applications. Processes. 2022;10(12):2595. doi:10.3390/pr10122595
   Web of Science ®Google Scholar
• Dening TJ, Zemlyanov D, Taylor LS. Application of an adsorption isotherm to explain incomplete drug release from ordered mesoporous silica materials under supersaturating conditions. J Control Release. 2019;307(March):186–199. doi:10.1016/j.jconrel.2019.06.028
   PubMedGoogle Scholar
• Qian KENK, Bogner RH. Spontaneous crystalline-to-amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 1 : thermodynamics of spontaneous amorphization. J Pharm Sci. 2011;100(7):2801–2815. doi:10.1002/jps
   PubMed Web of Science ®Google Scholar
• Mellaerts R, Jammaer JAG. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers : a case study with itraconazole and ibuprofen. Langmuir. 2008;24(16):8651–8659. doi:10.1021/la801161g
   PubMed Web of Science ®Google Scholar
• Van Speybroeck M, Mellaerts R, Mols R, et al. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica. Eur J Pharm Sci. 2010;41(5):623–630. doi:10.1016/j.ejps.2010.09.002
   PubMed Web of Science ®Google Scholar
• Mccarthy CA, Ahern RJ, Dontireddy R, Ryan KB, Crean AM. Mesoporous silica formulation strategies for drug dissolution enhancement: a review. Expert Opin Drug Deliv. 2016;13(1):93–108. doi:10.1517/17425247.2016.1100165
   PubMed Web of Science ®Google Scholar
• Skorupska E, Kaźmierski S, Potrzebowski MJ. Solid state NMR characterization of ibuprofen:nicotinamide cocrystals and new idea for controlling release of drugs embedded into mesoporous silica particles. Mol Pharm. 2017;14(5):1800–1810. doi:10.1021/acs.molpharmaceut.7b00092
   PubMedGoogle Scholar
• Skorupska E, Jeziorna A, Potrzebowski MJ. Thermal solvent-free method of loading of pharmaceutical cocrystals into the pores of silica particles: a Case of naproxen/picolinamide cocrystal. J Phys Chem C. 2016;120(24):13169–13180. doi:10.1021/acs.jpcc.6b05302
   Web of Science ®Google Scholar
• Bi Y, Xiao D, Ren S, Bi S, Wang J, Li F. The binary system of ibuprofen-nicotinamide under nanoscale confinement: from cocrystal to coamorphous state. J Pharm Sci. 2017;106(10):3150–3155. doi:10.1016/j.xphs.2017.06.005
   PubMed Web of Science ®Google Scholar
• Basavoju S, Boström D, Velaga SP. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization. Pharm Res. 2008;25(3):530–541. doi:10.1007/s11095-007-9394-1
   PubMed Web of Science ®Google Scholar
• Gao Y, Zu H, Zhang J. Enhanced dissolution and stability of Adefovir dipivoxil by cocrystal formation. J Pharm Pharmacol. 2011;63(4):483–490. doi:10.1111/j.2042-7158.2010.01246.x
   PubMed Web of Science ®Google Scholar
• Karki S, Friščić T, Fábián L, Laity PR, Day GM, Jones W. Improving mechanical properties of crystalline solids by cocrystal formation: new compressible forms of paracetamol. Adv Mater. 2009;21(38–39):3905–3909. doi:10.1002/adma.200900533
   Web of Science ®Google Scholar
• Good DJ, Rodríguez-Hornedo N. Solubility advantage of pharmaceutical cocrystals. Cryst Growth Des. 2009;9(5):2252–2264. doi:10.1021/cg801039j
   Web of Science ®Google Scholar
• Wouters J, Rome S, Quéré L. Monographs of Most Frequent Co-Crystal Formers; 2011.
   Google Scholar
• Blagden N, Colesb SJ, Berry DJ. Pharmaceutical co-crystals—are we there yet? Cryst Eng Comm. 2014;16(26):5753–5761. doi:10.1039/C4CE00127C
   Google Scholar
• Etter MC. Hydrogen bonds as design elements in organic chemistry. J Phys Chem. 1991;95(12):4601–4610. doi:10.1021/j100165a007
   Web of Science ®Google Scholar
• Kuminek G, Cao F, da Rocha ABDO, Cardoso SG, Rodríguez-Hornedo N. Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5. Adv Drug Deliv Rev. 2016;101:143–166. doi:10.1016/j.addr.2016.04.022
   PubMed Web of Science ®Google Scholar
• Etter MC. Encoding and decoding hydrogen-bond patterns of organic compounds. Acc Chem Res. 1990;23(4):120–126. doi:10.1021/ar00172a005
   Web of Science ®Google Scholar
• Donohue J. The hydrogen bond in organic crystals. J Phys Chem. 1952;56:502–510. doi:10.1021/j150496a023
   Web of Science ®Google Scholar
• Alhalaweh A, Roy L, Rodríguez-Hornedo N, Velaga SP. pH-dependent solubility of indomethacin-saccharin and carbamazepine- saccharin cocrystals in aqueous media. Mol Pharm. 2012;9(9):2605–2612. doi:10.1021/mp300189b
   PubMedGoogle Scholar
• Roy L, Lipert MP, Rodríguez-Hornedo N. Co-crystal solubility and thermodynamic stability. Pharm Salts Co-Crystals. 2012;2012;247–279.
   Google Scholar
• Good D, Miranda C, Rodríguez-Hornedo N. Dependence of cocrystal formation and thermodynamic stability on moisture sorption by amorphous polymer. CrystEngComm. 2011;13(4):1181–1189. doi:10.1039/c0ce00592d
   Web of Science ®Google Scholar
• Childs SL, Rodríguez-Hornedo N, Reddy LS, et al. Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine. CrystEngComm. 2008;10(7):856–864. doi:10.1039/b715396a
   Web of Science ®Google Scholar
• Chadha R, Saini A, Arora P, Jain DS, Dasgupta A, Guru Row TN. Multicomponent solids of lamotrigine with some selected coformers and their characterization by thermoanalytical, spectroscopic and X-ray diffraction methods. CrystEngComm. 2011;13(20):6271–6284. doi:10.1039/c1ce05458a
   Web of Science ®Google Scholar
• Laitinen R, Löbmann K, Grohganz H, Priemel P, Strachan CJ, Rades T. Supersaturating drug delivery systems: the potential of co-amorphous drug formulations. Int J Pharm. 2017;532(1):1–12. doi:10.1016/j.ijpharm.2017.08.123
   PubMedGoogle Scholar
• Sun DD, Wen H, Taylor LS. Non-sink dissolution conditions for predicting product quality and in vivo performance of supersaturating drug delivery systems. J Pharm Sci. 2016;105(9):2477–2488. doi:10.1016/j.xphs.2016.03.024
   PubMed Web of Science ®Google Scholar
• Taylor LS, Zhang GGZ. Physical chemistry of supersaturated solutions and implications for oral absorption. Adv Drug Deliv Rev. 2016;101:22–142. doi:10.1016/j.addr.2016.03.006
   PubMed Web of Science ®Google Scholar
• Wang R, Han J, Jiang A, et al. Involvement of metabolism-permeability in enhancing the oral bioavailability of curcumin in excipient-free solid dispersions co-formed with piperine. Int J Pharm. 2019;561(20):9–18. doi:10.1016/j.ijpharm.2019.02.027
   PubMedGoogle Scholar
• Wei Y, Zhou S, Hao T, et al. Further enhanced dissolution and oral bioavailability of docetaxel by coamorphization with a natural P-gp inhibitor myricetin. Eur J Pharm Sci. 2019;129:21–30. doi:10.1016/j.ejps.2018.12.016
   PubMed Web of Science ®Google Scholar
• Ojarinta R, Heikkinen AT, Sievänen E, Laitinen R. Dissolution behavior of co-amorphous amino acid-indomethacin mixtures: the ability of amino acids to stabilize the supersaturated state of indomethacin. Eur J Pharm Biopharm. 2017;112(85):85–95. doi:10.1016/j.ejpb.2016.11.023
   PubMedGoogle Scholar
• Kresge CT, Roth WJ. The discovery of mesoporous molecular sieves from the twenty year perspective. Chem Soc Rev. 2013;42(9):3663–3670. doi:10.1039/c3cs60016e
   PubMed Web of Science ®Google Scholar
• Bremmell KE, Prestidge CA. Enhancing oral bioavailability of poorly soluble drugs with mesoporous silica based systems: opportunities and challenges. Drug Dev Ind Pharm. 2019;45(3):349–358. doi:10.1080/03639045.2018.1542709
   PubMed Web of Science ®Google Scholar
• Maleki A, Kettiger H, Schoubben A, Rosenholm JM, Ambrogi V, Hamidi M. Mesoporous silica materials: from physico-chemical properties to enhanced dissolution of poorly water-soluble drugs. J Control Release. 2017;262:329–347. doi:10.1016/j.jconrel.2017.07.047
   PubMed Web of Science ®Google Scholar
• Diab R, Canilho N, Pavel IA, Haffner FB, Girardon M, Pasc A. Silica-based systems for oral delivery of drugs, macromolecules and cells. Adv Colloid Interface Sci. 2017;249:346–362. doi:10.1016/j.cis.2017.04.005
   PubMed Web of Science ®Google Scholar
• Simovic S, Ghouchi-Eskandar N, Moom Sinn A, et al. Silica materials in drug delivery applications. Curr Drug Discov Technol. 2011;8(3):250–268. doi:10.2174/157016311796799026
   PubMedGoogle Scholar
• Xu B, Li S, Shi R, et al. Multifunctional mesoporous silica nanoparticles for biomedical applications. Signal Transduct Target Ther. 2023;8(1):435. doi:10.1038/s41392-023-01654-7
   PubMed Web of Science ®Google Scholar
• McCarthy CA, Ahern RJ, Devine KJ, Crean AM. Role of drug adsorption onto the silica surface in drug release from mesoporous silica systems. Mol Pharm. 2018;15(1):141–149. doi:10.1021/acs.molpharmaceut.7b00778
   PubMedGoogle Scholar
• Martín A, Morales V, Ortiz-Bustos J, et al.. Modelling the adsorption and controlled release of drugs from the pure and amino surface-functionalized mesoporous silica hosts. Microporous Mesoporous Mater. 2018;262:23–24. doi:10.1016/j.micromeso.2017.11.009
   Web of Science ®Google Scholar
• Fu C, Liu T, Li L, Liu H, Chen D, Tang F. The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. Biomaterials. 2013;34(10):2565–2575. doi:10.1016/j.biomaterials.2012.12.043
   PubMed Web of Science ®Google Scholar
• Li L, Liu T, Fu C, et al. Biodistribution, excretion, and toxicity of mesoporous silica nanoparticles after oral administration depend on their shape. Nanomed Nanotech Biol Med. 2015;11(8):1915–1924. doi:10.1016/j.nano.2015.07.004
   PubMed Web of Science ®Google Scholar
• Huang X, Li L, Liu T, et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano. 2011;5(7):5390–5399. doi:10.1021/nn200365a
   PubMed Web of Science ®Google Scholar
• Hashim Ali K, Mohsin Ansari M, Ali Shah F, et al. Enhanced dissolution of valsartan-vanillin binary co-amorphous system loaded in mesoporous silica particles. J Microencapsul. 2019;36(1):10–20. doi:10.1080/02652048.2019.1579265
   PubMed Web of Science ®Google Scholar
• Budiman A, Higashi K, Ueda K, Moribe K. Effect of drug-coformer interactions on drug dissolution from a coamorphous in mesoporous silica. Int J Pharm. 2021;600(March):120492. doi:10.1016/j.ijpharm.2021.120492
   PubMedGoogle Scholar
• Ohta R, Ueno Y, Ajito K. Raman spectroscopy of pharmaceutical cocrystals in nanosized pores of mesoporous silica. Anal Sci. 2017;33(1):47–52. doi:10.2116/analsci.33.47
   PubMed Web of Science ®Google Scholar
• Salas-Zúñiga R, Mondragón-Vásquez K, Alcalá-Alcalá S, et al. Nanoconfinement of a pharmaceutical cocrystal with praziquantel in mesoporous silica: the influence of the solid form on dissolution enhancement. Mol Pharm. 2022;19(2):414–431. doi:10.1021/acs.molpharmaceut.1c00606
   PubMedGoogle Scholar
• Trzeciak K, Wielgus E, Kaźmierski S, et al.Unexpected factors affecting the kinetics of guest molecule release from investigation of binary chemical systems trapped in a single void of mesoporous silica particles. Eur J Chem Phys Phys Chem. 2022;24(7):25.
   Google Scholar
• Trzeciak K, Kaźmierski S, Wielgus E, Potrzebowski MJ. DiSupLo - new extremely easy and efficient method for loading of active pharmaceutical ingredients into the pores of MCM-41 mesoporous silica particles. Microporous Mesoporous Mater. 2020;308:110506. doi:10.1016/j.micromeso.2020.110506
   Web of Science ®Google Scholar
• Trzeciak K, Chotera‐ouda A, Bak‐sypien II, Potrzebowski MJ. Mesoporous silica particles as drug delivery systems—the state of the art in loading methods and the recent progress in analytical techniques for monitoring these processes. Pharmaceutics. 2021;13(7):950. doi:10.3390/pharmaceutics13070950
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. ICH guideline Q3C (R6) on impurities: guideline for residual solvents. Int Conf Harmon Tech Requir Regist Pharm Hum Use. 2019;31(August):1.
   Google Scholar
• Eren ZS, Tunçer S, Gezer G, Yildirim LT, Banerjee S, Yilmaz A. Improved solubility of celecoxib by inclusion in SBA-15 mesoporous silica: drug loading in different solvents and release. Microporous Mesoporous Mater. 2016;235:211–223. doi:10.1016/j.micromeso.2016.08.014
   Web of Science ®Google Scholar
• Hillerström A, van Stam J, Andersson M. Ibuprofen loading into mesostructured silica using liquid carbon dioxide as a solvent. Green Chem. 2009;11:662–667. doi:10.1039/b821281c
   Web of Science ®Google Scholar
• Belhadj-Ahmed F, Badens E, Llewellyn P, Denoyel R, Charbit G. Impregnation of vitamin E acetate on silica mesoporous phases using supercritical carbon dioxide. J Supercrit Fluids. 2009;51:278–286. doi:10.1016/j.supflu.2009.07.012
   Web of Science ®Google Scholar
• Lehto VP, Riikonen J. Drug Loading and Characterization of Porous Silicon Materials. Woodhead Publishing Limited; 2014. doi:10.1533/9780857097156.3.337
   Google Scholar
• Brás AR, Fonseca IM, Dionísio M, Schönhals A, Affouard F, Correia NT. Influence of nanoscale confinement on the molecular mobility of ibuprofen. J Phys Chem C. 2014;118(25):13857–13868. doi:10.1021/jp500630m
   Web of Science ®Google Scholar
• Wang Y, Zhao Q, Han N, et al. Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine Nanotechnology, Biol Med. 2015;11(2):313–327. doi:10.1016/j.nano.2014.09.014
   PubMed Web of Science ®Google Scholar
• Abd-Elbary A, El Nabarawi MA, Hassen DH, Taha AA. Inclusion and characterization of ketoprofen into different mesoporous silica nanoparticles using three loading methods. Int J Pharm Pharm Sci. 2014;6(9):183–191.
   Google Scholar
• He Y, Liang S, Long M, Xu H. Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel. Mater Sci Eng C. 2017;78:12–17. doi:10.1016/j.msec.2017.04.049
   PubMed Web of Science ®Google Scholar
• Uejo F, Limwikrant W, Moribe K, Yamamoto K. Dissolution improvement of fenofibrate by melting inclusion in mesoporous silica. Asian J Pharm Sci. 2013;8(6):329–335. doi:10.1016/j.ajps.2013.11.001
   Google Scholar
• Niu X, Wan L, Hou Z, et al. Mesoporous carbon as a novel drug carrier of fenofibrate for enhancement of the dissolution and oral bioavailability. Int J Pharm. 2013;452(1–2):382–389. doi:10.1016/j.ijpharm.2013.05.016
   PubMedGoogle Scholar
• Hampsey JE, De Castro CL, McCaughey B, Wang D, Mitchell BS, Lu Y. Preparation of micrometer- to sub-micrometer-sized nanostructured silica particles using high-energy ball milling. J Am Ceram Soc. 2004;87(7):1280–1286. doi:10.1111/j.1151-2916.2004.tb07723.x
   Web of Science ®Google Scholar
• Willart JF, Descamps M. ChemInform abstract: solid state amorphization of pharmaceuticals. ChemInform. 2009;40(3):905–920. doi:10.1002/chin.200903277
   Google Scholar
• Trzeciak K, Kaźmierski S, Drużbicki K, Potrzebowski MJ. Mapping of guest localization in mesoporous silica particles by solid-state NMR and Ab initio modeling: new insights into benzoic acid and p-fluorobenzoic acid embedded in MCM-41 via ball milling. J Phys Chem C. 2021;125(18):10096–10109. doi:10.1021/acs.jpcc.1c01675
   Web of Science ®Google Scholar
• Sing KS. Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity (Recommendations 1984). Pure Appl Chem. 1985;57(4):603–619. doi:10.1351/pac198557040603
   Web of Science ®Google Scholar
• Thommes M, Kaneko K, Neimark AV, et al.. Physisorption of gases, with special reference to the evaluation of surface area and pore size distribution (IUPAC technical report). Pure Appl Chem. 2015;87(9–10):1051–1069. doi:10.1515/pac-2014-1117
   Web of Science ®Google Scholar
• Rouquerol J, Avnir D, Everett DH, et al.. Guidelines for the characterization of porous solids. Stud Surf Sci Catal. 1994;87:1–9.
   Google Scholar
• Zhang Y, Wang J, Bai X, Jiang T, Zhang Q, Wang S. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs. Mol Pharm. 2012;9(3):505–513. doi:10.1021/mp200287c
   PubMedGoogle Scholar
• Sayed E, Karavasili C, Ruparelia K, et al. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation. J Control Release. 2018;278:142–155. doi:10.1016/j.jconrel.2018.03.031
   PubMed Web of Science ®Google Scholar
• Giunchedi P, Juliano C, Gavini E, Cossu M, Sorrenti M. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. Eur J Pharm Biopharm. 2002;53(2):233–239. doi:10.1016/S0939-6411(01)00237-5
   PubMed Web of Science ®Google Scholar
• Laitinen R, Löbmann K, Grohganz H, Strachan C, Rades T. Amino acids as Co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability. Mol Pharm. 2014;11(7):2381–2389. doi:10.1021/mp500107s
   PubMed Web of Science ®Google Scholar
• Yamamura S, Gotoh H, Sakamoto Y, Momose Y. Physicochemical properties of amorphous precipitates of cimetidine-indomethacin binary system. Eur J Pharm Biopharm. 2000;49(3):259–265. doi:10.1016/S0939-6411(00)00060-6
   PubMed Web of Science ®Google Scholar
• Wang J, Chang R, Zhao Y, et al. Coamorphous loratadine-citric acid system with enhanced physical stability and bioavailability. AAPS Pharm Sci Tech. 2017;18(7):2541–2550. doi:10.1208/s12249-017-0734-0
   PubMed Web of Science ®Google Scholar
• Nartowski KP, Tedder J, Braun DE, Fábián L, Khimyak YZ. Building solids inside nano-space: from confined amorphous through confined solvate to confined “metastable” polymorph. Phys Chem Chem Phys. 2015;17(38):24761–24773. doi:10.1039/c5cp03880d
   PubMed Web of Science ®Google Scholar
• Nartowski KP, Malhotra D, Hawarden LE, Fábián L, Khimyak YZ. Nanocrystallization of rare tolbutamide form V in mesoporous MCM-41 Silica. Mol Pharm. 2018;15:4926–4932. doi:10.1021/acs.molpharmaceut.8b00575s
   PubMedGoogle Scholar
• Hamilton BD, Ha JM, Hillmyer MA, Ward MD. Manipulating crystal growth and polymorphism by confinement in nanoscale crystallization chambers. Acc Chem Res. 2012;45(3):414–423. doi:10.1021/ar200147v
   PubMed Web of Science ®Google Scholar
• Dwyer LM, Michaelis VK, O’Mahony M, Griffin RG, Myerson AS. Confined crystallization of fenofibrate in nanoporous silica. CrystEngComm. 2015;17(41):7922–7929. doi:10.1039/c5ce01148e
   PubMed Web of Science ®Google Scholar
• Cheng S, McKenna GB. Nanoconfinement effects on the glass transition and crystallization behaviors of nifedipine. Mol Pharm. 2019;16(2):856–866. doi:10.1021/acs.molpharmaceut.8b01172
   PubMedGoogle Scholar
• Koh YP, Simon SL. Trimerization of monocyanate ester in nanopores. J Phys Chem B. 2010;114(23):7727–7734. doi:10.1021/jp912235c
   PubMed Web of Science ®Google Scholar
• Li W, Quan P, Zhang Y, et al. Influence of drug physicochemical properties on absorption of water insoluble drug nanosuspensions. Int J Pharm. 2014;460(1–2):13–23. doi:10.1016/j.ijpharm.2013.10.038
   PubMed Web of Science ®Google Scholar
• Li Q, Simon SL. Curing of bisphenol M dicyanate ester under nanoscale constraint. Macromolecules. 2008;41(4):1310–1317. doi:10.1021/ma702144b
   Web of Science ®Google Scholar
• Wu H, Xiao Y, Guo Y, Miao S, Chen Q, Chen Z. Functionalization of SBA-15 mesoporous materials with 2-acetylthiophene for adsorption of Cr(III) ions. Microporous Mesoporous Mater. 2020;292(May 2019):109754. doi:10.1016/j.micromeso.2019.109754
   Google Scholar
• Melnyk IV, Nazarchuk GI, Václavíková M, Zub YL. IR spectroscopy study of SBA-15 silicas functionalized with the ethylthiocarbamidepropyl groups and their interactions with Ag (I) and Hg (II) ions. Appl Nanosci. 2019;9:683–694. doi:10.1007/s13204-018-0761-5
   Web of Science ®Google Scholar
• Tomozawa M, Hong JW, Ryu SR. Infrared (IR) investigation of the structural changes of silica glasses with fictive temperature. J Non Cryst Solids. 2005;351(12–13):1054–1060. doi:10.1016/j.jnoncrysol.2005.01.017
   Web of Science ®Google Scholar
• Acharya M, Mishra S, Sahoo RN, Mallick S. Infrared spectroscopy for analysis of co-processed ibuprofen and magnesium trisilicate at milling and freeze drying. Acta Chim Slov. 2017;64(1):45–54. doi:10.17344/acsi.2016.2772
   PubMed Web of Science ®Google Scholar
• Kinnari P, Mäkilä E, Heikkilä T, Salonen J, Hirvonen J, Santos HA. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole. Int J Pharm. 2011;414(1–2):148–156. doi:10.1016/j.ijpharm.2011.05.021
   PubMed Web of Science ®Google Scholar
• Peng H, Xiong H, Li J, et al. Vanillin cross-linked chitosan microspheres for controlled release of resveratrol. Food Chem. 2010;121(1):23–28. doi:10.1016/j.foodchem.2009.11.085
   Web of Science ®Google Scholar
• Kong K, Kendall C, Stone N, Notingher I. Raman spectroscopy for medical diagnostics - from in-vitro biofluid assays to in-vivo cancer detection. Adv Drug Deliv Rev. 2015;89:121–134. doi:10.1016/j.addr.2015.03.009
   PubMed Web of Science ®Google Scholar
• Huang N, Short M, Zhao J, et al.. Full range characterization of the Raman spectra of organs in a murine model. Opt Express. 2011;19(23):22892–22909. doi:10.1364/OE.19.022892
   PubMed Web of Science ®Google Scholar
• Li S, Chen G, Zhang Y, et al.. Identification and characterization of colorectal cancer using Raman spectroscopy and feature selection techniques. Opt Express. 2014;22(21):25895–25908. doi:10.1364/OE.22.025895
   PubMed Web of Science ®Google Scholar
• Ajito K, Han C, Torimitsu K. Detection of glutamate in optically trapped single nerve terminals by Raman spectroscopy. Anal Chem. 2004;76(9):2506–2510. doi:10.1021/ac049969m
   PubMed Web of Science ®Google Scholar
• Moser C, Havermeyer F. Ultra-narrow-band tunable laserline notch filter. Appl Phys B Lasers Opt. 2009;95(3):597–601. doi:10.1007/s00340-009-3447-6
   Web of Science ®Google Scholar
• Parrott EPJ, Zeitler JA. Terahertz time-domain and low-frequency Raman spectroscopy of organic materials. Appl Spectrosc. 2015;69(1):1–25. doi:10.1366/14-07707
   PubMed Web of Science ®Google Scholar
• Hédoux A, Decroix AA, Guinet Y, Paccou L, Derollez P, Descamps M. Low- and high-frequency Raman investigations on caffeine: polymorphism, disorder and phase transformation. J Phys Chem B. 2011;115(19):5746–5753. doi:10.1021/jp112074w
   PubMed Web of Science ®Google Scholar
• Allesø M, Velaga S, Alhalaweh A, et al. Near-infrared spectroscopy for cocrystal screening. A comparative study with Raman spectroscopy. Anal Chem. 2008;80(20):7755–7764. doi:10.1021/ac8011329
   PubMed Web of Science ®Google Scholar
• Edwards HGM, Munshi T, Anstis M. Raman spectroscopic characterisations and analytical discrimination between caffeine and demethylated analogues of pharmaceutical relevance. Spectrochim Acta - Part A Mol Biomol Spectrosc. 2005;61(7):1453–1459. doi:10.1016/j.saa.2004.10.022
   PubMed Web of Science ®Google Scholar
• Pavel I, Szeghalmi A, Moigno D, Cîntă S, Kiefer W. Theoretical and pH dependent surface enhanced Raman spectroscopy study on caffeine. Biopolym Orig Res Biomol. 2003;72(1):25–37.
   Google Scholar
• Kang J, Gu H, Zhong L, Hu Y, Liu F. The pH dependent Raman spectroscopic study of caffeine. Spectrochimica acta part A. Mol Biomol Spectrosc. 2011;78(2):757–762. doi:10.1016/j.saa.2010.11.055
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge EM, Liversidge GG. Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol Pathol. 2008;36(1):43–48. doi:10.1177/0192623307310946
   PubMed Web of Science ®Google Scholar
• Geppi M, Mollica G, Borsacchi S, Veracini CA. Solid-state NMR studies of pharmaceutical systems. Appl Spectrosc Rev. 2008;43(3):202–302. doi:10.1080/05704920801944338
   Web of Science ®Google Scholar
• Trébosc J, Wiench JW, Huh S, Lin VSY, Pruski M. Solid-state MMR study of MCM-41-type mesoporous silica nanoparticles. J Am Chem Soc. 2005;127(9):3057–3068. doi:10.1021/ja043567e
   PubMed Web of Science ®Google Scholar
• Trebosc J, Wiench JW, Huh S, Lin VSY, Pruski M. Studies of organically functionalized mesoporous silicas using heteronuclear solid-state correlation NMR spectroscopy under fast magic angle spinning. J Am Chem Soc. 2005;127(20):7587–7593. doi:10.1021/ja0509127
   PubMed Web of Science ®Google Scholar
• Wiench JW, Avadhut YS, Maity N, et al.. Characterization of covalent linkages in organically functionalized MCM-41 mesoporous materials by solid-state NMR and theoretical calculations. J Phys Chem B. 2007;111(15):3877–3885. doi:10.1021/jp067417x
   PubMed Web of Science ®Google Scholar
• Mao K, Kobayashi T, Wiench JW, et al.. Conformations of silica-bound (pentafluorophenyl) propyl groups determined by solid-state NMR spectroscopy and theoretical calculations. J Am Chem Soc. 2010;132(35):12452–12457. doi:10.1021/ja105007b
   PubMed Web of Science ®Google Scholar
• Baccile N. Application of advanced solid-state nmr techniques to the characterization of nanomaterials: a focus on interfaces and structure; 2010.
   Google Scholar
• Shenderovich IG, Limbach HH. Solid state NMR for nonexperts: an overview of simple but general practical methods. Solids. 2021;2(2):139–154. doi:10.3390/solids2020009
   Google Scholar
• Qian KK, Bogner RH. Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems. J Pharm Sci. 2012;101(7):2271–2280. doi:10.1002/jps
   PubMedGoogle Scholar
• Chieng N, Aaltonen J, Saville D, Rades T. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation. Eur J Pharm Biopharm. 2009;71(1):47–54. doi:10.1016/j.ejpb.2008.06.022
   PubMed Web of Science ®Google Scholar
• Kissi EO, Ruggiero MT, Hempel NJ, et al. Characterising glass transition temperatures and glass dynamics in mesoporous silica-based amorphous drugs. Phys Chem Chem Phys. 2019;21(35):19686–19694. doi:10.1039/c9cp01764j
   PubMed Web of Science ®Google Scholar
• Paul R, Chattaraj KG, Paul S. Role of hydrotropes in sparingly soluble drug solubilization: insight from a molecular dynamics simulation and experimental perspectives. Langmuir. 2021;37(16):4745–4762. doi:10.1021/acs.langmuir.1c00169
   PubMed Web of Science ®Google Scholar